2. Membrane Transporter/Ion Channel
  3. NKCC
  4. Bendroflumethiazide

Bendroflumethiazide  (Synonyms: Bendrofluazide)

Cat. No.: HY-B1363 Pureza: 99.16%
COA
SDS
Instrucciones de manejo Technical Support

Bendroflumethiazide (Bendrofluazide) is an orally available diuretic. Bendroflumethiazide inhibits the electroneutral sodium-chloride symporter located in the apical membrane of the early segment of the distal convoluted tubule and can effectively lower blood pressure. Bendroflumethiazide is used in the study of hypertension and edema. Bendroflumethiazide has an antidiuretic effect in diabetes insipidus.

Para uso exclusivo en investigación. No vendemos a pacientes.

Bendroflumethiazide

Bendroflumethiazide Estructura química

No. CAS : 73-48-3

Tamaño Precio Stock Cantidad
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
 En stock
Solution
10 mM * 1 mL in DMSO En stock
Solid
50 mg En stock
100 mg En stock
200 mg En stock
500 mg   Obtener un presupuesto  
1 g   Obtener un presupuesto  

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

Revisión del cliente

Based on 1 Customer Validation

Other Forms of Bendroflumethiazide:

Bendroflumethiazide Related Antibodies

Top Publications Citing Use of Products

  • Actividad biológica

  • Pureza y Documentación

  • Referencias

  • Revisión del cliente

Descripciòn

Bendroflumethiazide (Bendrofluazide) is an orally available diuretic. Bendroflumethiazide inhibits the electroneutral sodium-chloride symporter located in the apical membrane of the early segment of the distal convoluted tubule and can effectively lower blood pressure. Bendroflumethiazide is used in the study of hypertension and edema. Bendroflumethiazide has an antidiuretic effect in diabetes insipidus[1][2].

In Vivo

Bendroflumethiazide (125 mg/kg, p.o. 12 days) reduces body weight, decreases urine flow, and increases urine osmolality in the Brattleboro rat model of diabetes insipidus, exerts an antidiuretic effect through sustained sodium loss[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Brattleboro rats with hereditary DI (female 200 g) [2]
Dosage: 125 mg/kg
Administration: p.o., 12 days
Result: Showed a weight loss of approximately 3%, but did not change average daily food intake.
Reduced urine flow, increased urine osmotic pressure, and reduced free water clearance.
Ensayo clínico
Peso molecular

421.41

Fòrmula

C15H14F3N3O4S2
No. CAS
Appearance

Solid

Color

Off-white to light yellow

SMILES

O=S(C1=C(C(F)(F)F)C=C(C2=C1)NC(CC3=CC=CC=C3)NS2(=O)=O)(N)=O
Envío

Room temperature in continental US; may vary elsewhere.
Almacenamiento
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Solvente y solubilidad
In Vitro: 

DMSO : 250 mg/mL (593.25 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.3730 mL 11.8649 mL 23.7299 mL
5 mM 0.4746 mL 2.3730 mL 4.7460 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Calculadora de molaridad

  • Calculadora de dilución

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Pureza y Documentación
Referencias

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.3730 mL 11.8649 mL 23.7299 mL 59.3246 mL
5 mM 0.4746 mL 2.3730 mL 4.7460 mL 11.8649 mL
10 mM 0.2373 mL 1.1865 mL 2.3730 mL 5.9325 mL
15 mM 0.1582 mL 0.7910 mL 1.5820 mL 3.9550 mL
20 mM 0.1186 mL 0.5932 mL 1.1865 mL 2.9662 mL
25 mM 0.0949 mL 0.4746 mL 0.9492 mL 2.3730 mL
30 mM 0.0791 mL 0.3955 mL 0.7910 mL 1.9775 mL
40 mM 0.0593 mL 0.2966 mL 0.5932 mL 1.4831 mL
50 mM 0.0475 mL 0.2373 mL 0.4746 mL 1.1865 mL
60 mM 0.0395 mL 0.1977 mL 0.3955 mL 0.9887 mL
80 mM 0.0297 mL 0.1483 mL 0.2966 mL 0.7416 mL
100 mM 0.0237 mL 0.1186 mL 0.2373 mL 0.5932 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Bendroflumethiazide Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Bendroflumethiazide73-48-3BendrofluazideNKCCNa-K-Cl cotransporterNa(+)-K(+)-Cl(-) cotransporterNa+-K+-Cl− cotransporteroraldiureticantihypertensivearterial hypertensive diseaseBrattleboro ratsdiabetes insipidus,Inhibitorinhibitorinhibit

Productos vistos recientemente:

Consulta en línea

Your information is safe with us. * Required Fields.

Nombre del producto

  

Requested Quantity *

Nombre del solicitante *

 

Saludo

Direcciòn del E-mail *

 

Número de teléfono *

Department

 

Nombre de la Organizaciòn *

City

Provincia

Country or Region *

      

Observaciones

Consulta para venta a granel

Inquiry Information

Nombre del producto:
Bendroflumethiazide
Cat. No.:
HY-B1363
Cantidad:
MCE Japan Authorized Agent:

Revisión del cliente

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Nombre del producto

  

Lot #

Nombre del solicitante *

 

Direcciòn del E-mail *

Número de teléfono

 

Department *

Nombre de la Organizaciòn *

 

Country or Region *

Observaciones

SAFETY DATA SHEET (SDS)

English - EN (393 KB) Français - FR (393 KB) Deutsch - DE (393 KB) Norwegian - NO (393 KB) Español - ES (393 KB) Swedish - SV (393 KB) Italian - IT (393 KB) Korean - KR (393 KB) Portuguese - PT (393 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.